Non Coding RNAs as Regulators of Wnt/β-Catenin and Hippo Pathways in Arrhythmogenic Cardiomyopathy

Area of Science:

• Cardiovascular Genetics
• Molecular Biology
• RNA Biology

Background:

• Arrhythmogenic cardiomyopathy (ACM) is an inherited condition characterized by fibrofatty myocardial replacement and inflammation.
• ACM is often termed a desmosomal disease due to mutations in desmosomal protein genes.
• Perturbed Wnt/β-catenin and Hippo pathways are implicated in ACM pathogenesis, promoting pro-adipogenic and pro-fibrotic gene expression.

Purpose of the Study:

• To investigate the role of non-coding RNAs (ncRNAs) in modulating Wnt/β-catenin and Hippo pathways in ACM.
• To explore ncRNAs as potential therapeutic targets for ACM progression.

Main Methods:

• Review of current literature on ACM, desmosomal genes, Wnt/β-catenin and Hippo pathways.
• Analysis of the potential roles of various ncRNA types, including competing endogenous RNAs (ceRNAs).
• Exploration of cancer research findings on ceRNAs in Wnt/β-catenin and Hippo pathway modulation.

Main Results:

• The study highlights the intricate connection between desmosomal dysfunction, Wnt/β-catenin, and Hippo pathway dysregulation in ACM.
• ncRNAs, especially ceRNAs, are identified as key regulators capable of fine-tuning gene expression.
• ceRNAs show promise in coordinating actions within the Wnt/β-catenin and Hippo signaling networks.

Conclusions:

• ncRNAs represent a significant area for understanding ACM molecular mechanisms.
• ceRNAs offer potential actionable targets for therapeutic strategies in arrhythmogenic cardiomyopathy.
• Further research into ncRNA-mediated regulation of key pathways is crucial for advancing ACM treatment.